José Pedro Planco Panadés Gil
AuthID: R-000-J1J
1
TITLE: An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria
AUTHORS: Pernaute Lau, Leyre; Camara, Mahamadou; de Sousa, Tais Nobrega; Morris, Ulrika ; Ferreira, Marcelo Urbano; Gil, Jose Pedro;
PUBLISHED: 2022, SOURCE: EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, VOLUME: 18, ISSUE: 1
AUTHORS: Pernaute Lau, Leyre; Camara, Mahamadou; de Sousa, Tais Nobrega; Morris, Ulrika ; Ferreira, Marcelo Urbano; Gil, Jose Pedro;
PUBLISHED: 2022, SOURCE: EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, VOLUME: 18, ISSUE: 1
INDEXED IN: 
Scopus 
WOS
Scopus WOS2
TITLE: Plasmodium falciparum Drug Resistance Genes pfmdr1 and pfcrt In Vivo Co-Expression During Artemether-Lumefantrine Therapy Full Text
AUTHORS: Silva, M.; Malmberg, M.; Otienoburu, S. D.; Bjorkman, A.; Ngasala, B.; Martensson, A.; Gil, J. P.; Veiga, M. I.;
PUBLISHED: 2022, SOURCE: FRONTIERS IN PHARMACOLOGY, VOLUME: 13
AUTHORS: Silva, M.; Malmberg, M.; Otienoburu, S. D.; Bjorkman, A.; Ngasala, B.; Martensson, A.; Gil, J. P.; Veiga, M. I.;
PUBLISHED: 2022, SOURCE: FRONTIERS IN PHARMACOLOGY, VOLUME: 13
INDEXED IN: WOS
WOS3
TITLE: Influence of cytochrome P450 (CYP) 2C8 polymorphisms on the efficacy and tolerability of artesunate-amodiaquine treatment of uncomplicated Plasmodium falciparum malaria in Zanzibar Full Text
AUTHORS: Pernaute Lau, L; Morris, U ; Msellem, M; Martensson, A; Bjorkman, A; Gil, JP;
PUBLISHED: 2021, SOURCE: MALARIA JOURNAL, VOLUME: 20, ISSUE: 1
AUTHORS: Pernaute Lau, L; Morris, U ; Msellem, M; Martensson, A; Bjorkman, A; Gil, JP;
PUBLISHED: 2021, SOURCE: MALARIA JOURNAL, VOLUME: 20, ISSUE: 1
INDEXED IN: Scopus WOS
Scopus WOS4
TITLE: Pharmacogene Sequencing of a Gabonese Population with Severe Plasmodium falciparum Malaria Reveals Multiple Novel Variants with Putative Relevance for Antimalarial Treatment
AUTHORS: Pernaute Lau, L; Adegnika, AA; Zhou, YT; Zinsou, JF; Gil, JP; Krishna, S; Kremsner, PG; Lauschke, VM; Velavan, TP;
PUBLISHED: 2021, SOURCE: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, VOLUME: 65, ISSUE: 7
AUTHORS: Pernaute Lau, L; Adegnika, AA; Zhou, YT; Zinsou, JF; Gil, JP; Krishna, S; Kremsner, PG; Lauschke, VM; Velavan, TP;
PUBLISHED: 2021, SOURCE: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, VOLUME: 65, ISSUE: 7
INDEXED IN: Scopus WOS
Scopus WOS5
TITLE: Plasmodium falciparum Multidrug Resistance Proteins (pfMRPs) Full Text
AUTHORS: Gil, JP; Fancony, C;
PUBLISHED: 2021, SOURCE: FRONTIERS IN PHARMACOLOGY, VOLUME: 12
AUTHORS: Gil, JP; Fancony, C;
PUBLISHED: 2021, SOURCE: FRONTIERS IN PHARMACOLOGY, VOLUME: 12
INDEXED IN: Scopus WOS
Scopus WOS6
TITLE: Challenges and Opportunities for Clinical Pharmacogenetic Research Studies in Resource-limited Settings: Conclusions From the Council for International Organizations of Medical Sciences-Ibero-American Network of Pharmacogenetics and Pharmacogenomics Meeting Full Text
AUTHORS: Eva Penas LLedo; Enrique Teran; Marta Sosa Macias; Carlos Galaviz Hernandez; Jose Pedro Gil; Sujit Nair; Shyam Diwakar; Isabel Hernandez; Julio Lara Riegos; Ronald Ramirez Roa; Ignacio Verde; Eduardo Tarazona Santos; Juan Molina Guarneros; Graciela Moya; Lembit Raego; Adrian LLerena;
PUBLISHED: 2020, SOURCE: CLINICAL THERAPEUTICS, VOLUME: 42, ISSUE: 8
AUTHORS: Eva Penas LLedo; Enrique Teran; Marta Sosa Macias; Carlos Galaviz Hernandez; Jose Pedro Gil; Sujit Nair; Shyam Diwakar; Isabel Hernandez; Julio Lara Riegos; Ronald Ramirez Roa; Ignacio Verde; Eduardo Tarazona Santos; Juan Molina Guarneros; Graciela Moya; Lembit Raego; Adrian LLerena;
PUBLISHED: 2020, SOURCE: CLINICAL THERAPEUTICS, VOLUME: 42, ISSUE: 8
INDEXED IN: WOS
WOS7
TITLE: Prevalence of CYP2C8*2 and *3 among Eritreans and its Potential Impact on Artesunate/Amodiaquine Treatment Full Text
AUTHORS: Lidia Habtemikael; Mulugeta Russom; Iyassu Bahta; Selam Mihreteab; Araia Berhane; Andreas Martensson; Jose Pedro Gil;
PUBLISHED: 2020, SOURCE: PHARMACOGENOMICS & PERSONALIZED MEDICINE, VOLUME: 13
AUTHORS: Lidia Habtemikael; Mulugeta Russom; Iyassu Bahta; Selam Mihreteab; Araia Berhane; Andreas Martensson; Jose Pedro Gil;
PUBLISHED: 2020, SOURCE: PHARMACOGENOMICS & PERSONALIZED MEDICINE, VOLUME: 13
INDEXED IN: Scopus WOS
Scopus WOS8
TITLE: Plasmodium falciparum K13 expression associated with parasite clearance during artemisinin-based combination therapy
AUTHORS: Silva, M; Ferreira, PE; Otienoburu, SD; Calcada, C; Ngasala, B; Bjorkman, A; Martensson, A; Gil, JP; Veiga, MI;
PUBLISHED: 2019, SOURCE: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, VOLUME: 74, ISSUE: 7
AUTHORS: Silva, M; Ferreira, PE; Otienoburu, SD; Calcada, C; Ngasala, B; Bjorkman, A; Martensson, A; Gil, JP; Veiga, MI;
PUBLISHED: 2019, SOURCE: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, VOLUME: 74, ISSUE: 7
INDEXED IN: Scopus WOS
Scopus WOS9
TITLE: Plasmodium falciparum Plasmepsin 2 Duplications, West Africa Full Text
AUTHORS: Juliana Inoue; Miguel Silva; Bakary Fofana; Kassim Sanogo; Andreas Martensson; Issaka Sagara; Anders Bjorkman; Maria Isabel Veiga; Pedro Eduardo Ferreira; Abdoulaye Djimde; Jose Pedro Gil;
PUBLISHED: 2018, SOURCE: EMERGING INFECTIOUS DISEASES, VOLUME: 24, ISSUE: 8
AUTHORS: Juliana Inoue; Miguel Silva; Bakary Fofana; Kassim Sanogo; Andreas Martensson; Issaka Sagara; Anders Bjorkman; Maria Isabel Veiga; Pedro Eduardo Ferreira; Abdoulaye Djimde; Jose Pedro Gil;
PUBLISHED: 2018, SOURCE: EMERGING INFECTIOUS DISEASES, VOLUME: 24, ISSUE: 8
INDEXED IN: Scopus WOS
Scopus WOS10
TITLE: The drug transporter ABCB1 c.3435C>T SNP influences artemether-lumefantrine treatment outcome Full Text
AUTHORS: Kinanga Kiaco; Antonio Sebastiao Rodrigues; Virgilio do Rosario; Jose Pedro Gil; Dinora Lopes;
PUBLISHED: 2017, SOURCE: MALARIA JOURNAL, VOLUME: 16, ISSUE: 1
AUTHORS: Kinanga Kiaco; Antonio Sebastiao Rodrigues; Virgilio do Rosario; Jose Pedro Gil; Dinora Lopes;
PUBLISHED: 2017, SOURCE: MALARIA JOURNAL, VOLUME: 16, ISSUE: 1
INDEXED IN: Scopus WOS
Scopus WOS